Development of Replication-Defective HIV as Vaccine Candidate

NIH RePORTER · NIH · N43 · $300,000 · view on reporter.nih.gov ↗

Abstract

Novel Platforms for Delivery and/or Expression of HIV Env Immunogens for HIV Vaccines: Efforts towards the development of an efficacious HIV vaccine have focused on improvements in the design of the HIV envelope (Env) immunogen for induction and generation of broadly neutralizing antibody (bNAb) responses and novel platforms for immunogen delivery. The goal of this program is to develop an HIV vaccine platform for delivery of HIV Env immunogens that induce bnAbs and to demonstrate that the vaccine platform/immunogen proposed will elicit a strong and durable NAb HIV Env response.

Key facts

NIH application ID
10667356
Project number
75N93022C00013-0-9999-1
Recipient
GENECURE, LLC
Principal Investigator
FRANK TUNG
Activity code
N43
Funding institute
NIH
Fiscal year
2022
Award amount
$300,000
Award type
Project period
2022-07-01 → 2023-06-30